Wave Life Sciences (WVE) Other Non Operating Income (2014 - 2026)
Wave Life Sciences (WVE) posted Other Non Operating Income of -$80000.0 for Q1 2026, down 134.19% on a QoQ basis from $234000.0 in Q4 2025, and down 256.86% year-over-year from $51000.0 in Q1 2025.
Wave Life Sciences (WVE) Other Non Operating Income (2014 - 2026) Analysis & Trends
Wave Life Sciences' Other Non Operating Income history runs 13 years deep, the most recent figure standing at -$80000.0 for Q1 2026.
- Quarterly Other Non Operating Income fell 256.86% year-over-year to -$80000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $396000.0 (down 86.43% YoY) and the FY2025 annual result came in at $527000.0, down 83.69% from the prior year.
- Other Non Operating Income was -$80000.0 for Q1 2026 at Wave Life Sciences, down from $234000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $2.5 million in Q4 2024 and bottomed at -$701000.0 in Q3 2022.
- A 5-year average of $327294.1 and a median of $234000.0 in 2025 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2024 — Other Non Operating Income soared 337.8% — and 2025, when it tumbled 355.56%.
- Wave Life Sciences' Other Non Operating Income stood at -$290000.0 in 2022, then surged by 300.69% to $582000.0 in 2023, then jumped by 337.8% to $2.5 million in 2024, then sank by 90.82% to $234000.0 in 2025, then slumped by 134.19% to -$80000.0 in 2026.
- Business Quant data shows WVE's Other Non Operating Income at -$80000.0 in Q1 2026, $234000.0 in Q4 2025, and $324000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Wave Life Sciences | 1.19 Bn | 649.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -80,000.00 |
| Dec 31, 2025 | 234,000.00 |
| Sep 30, 2025 | 324,000.00 |
| Jun 30, 2025 | -82,000.00 |
| Mar 31, 2025 | 51,000.00 |
| Dec 31, 2024 | 2.55 Mn |
| Sep 30, 2024 | 337,000.00 |
| Jun 30, 2024 | -18,000.00 |
| Mar 31, 2024 | 365,000.00 |
| Dec 31, 2023 | 582,000.00 |
| Sep 30, 2023 | 171,000.00 |
| Jun 30, 2023 | 118,000.00 |
| Mar 31, 2023 | 1.01 Mn |
| Dec 31, 2022 | -290,000.00 |
| Sep 30, 2022 | -701,000.00 |
| Jun 30, 2022 | 744,000.00 |
| Mar 31, 2022 | 254,000.00 |
| Dec 31, 2021 | 1.12 Mn |
| Sep 30, 2021 | 1.37 Mn |
| Jun 30, 2021 | 1.05 Mn |